Enhertu 100 MG vials
Ended Awarded
- Contract number
- SPE2DB25FNWTM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,222
Award facts
- Contract value 100% obligated
- $14,221.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Enhertu 100 mg vials, a specialty pharmaceutical product used in cancer treatment. This firm fixed-price delivery order, valued at $14,221.60, is scheduled for completion by October 14, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability to meet federal medical procurement requirements.
This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical commodities to support military healthcare systems and other federal agencies, including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen maintains an extensive portfolio of federal contracts encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FNWTM?
SPE2DB25FNWTM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FNWTM worth?
The government has obligated $14,222 on SPE2DB25FNWTM.
Is contract SPE2DB25FNWTM an order under another contract?
Yes. SPE2DB25FNWTM is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNWTM competed?
The extent of competition for SPE2DB25FNWTM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award